bioengineer.org
/3 hours ago
Anti-PD-1 Therapy Modulates HIV-Specific CD8+ T Cells in Men with HIV
A clinical trial of anti-PD-1 therapy in men with HIV and cancer demonstrates complex changes in HIV-specific CD8+ T-cell phenotypes and clonal distribution.